S
Stereotaxis Inc
AMEX:STXS
Stereotaxis Inc
AMEX:STXS
Price:
1.8
USD
-2.17%
Market Closed
Market Cap:
$175.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
S
|
Stereotaxis Inc
AMEX:STXS
|
US |
|
C
|
Clio Cosmetics Co Ltd
KOSDAQ:237880
|
KR |
|
A
|
Aerowash AB (Publ)
F:1HV
|
SE |
|
T
|
Tonghua Golden-Horse Pharmaceutical Industry Co Ltd
SZSE:000766
|
CN |
|
H
|
Haoxin Holdings Ltd
NASDAQ:HXHX
|
CN |
|
E
|
Enel Chile SA
SGO:ENELCHILE
|
CL |
Relative Value
The Relative Value of one STXS stock under the Base Case scenario is hidden USD. Compared to the current market price of 1.8 USD, Stereotaxis Inc is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
STXS Relative Value
HIDDEN
Multiples Across Competitors
STXS Competitors Multiples
Stereotaxis Inc Competitors
Stereotaxis Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
S
|
Stereotaxis Inc
AMEX:STXS
|
171.6m USD | 5.3 | -7.5 | -8.4 | -7.7 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
180.7B USD | 4.1 | 27.7 | 15.9 | 21.8 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
167.6B USD | 16.6 | 58.7 | 44.5 | 54.7 | |
| US |
|
Stryker Corp
NYSE:SYK
|
125.7B USD | 5 | 38.7 | 19.8 | 24 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
111.1B USD | 3.1 | 24.1 | 13.3 | 19.4 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
101.1B USD | 5 | 34.9 | 20.5 | 27.6 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
41.4B EUR | 1.8 | 19.6 | 11 | 15.5 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
47.4B USD | 7.8 | 44.2 | 24.3 | 26.6 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
45.5B USD | 10.6 | 42.9 | 30.4 | 33.7 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
44.4B USD | 2 | 25.3 | 10 | 16.9 | |
| US |
|
Resmed Inc
NYSE:RMD
|
33.2B USD | 6.2 | 22.4 | 15.7 | 17.5 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
